Codes J1790 to J2860
Page 3 of 6 of the hub's 847 codes, in code order: 148 codes on this page have an indexed reference page and are in the table, and the other 7 are listed as text below it.
| Code | Descriptor | Unit | Limit | MUE | Col-2 pairs | Articles |
|---|---|---|---|---|---|---|
| J1790 | Injection, droperidol, up to 5 mg | up to 5 MG | $5.348 | 2 | — | — |
| J1805 | Injection, esmolol hydrochloride, 10 mg | 10 MG | $0.246 | — | — | — |
| J1806 | Injection, esmolol hydrochloride (wg critical care), not therapeutically equivalent to j1805, 10 mg | 10 MG | $0.196 | — | — | — |
| J1808 | Injection, folic acid, 0.1 mg | 0.1 MG | $0.053 | 150 | — | — |
| J1809 | Injection, fosdenopterin, 0.1 mg | 0.1 MG | $17.736 | — | — | — |
| J1811 | Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units | 50 UNITS | $1.181 | — | — | — |
| J1813 | Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units | 50 UNITS | $3.903 | — | — | — |
| J1817 | Insulin for administration through dme (i.e., insulin pump) per 50 units | 50 UNITS | $3.116 | 0 | — | — |
| J1823 | Injection, inebilizumab-cdon, 1 mg | 1 MG | $511.573 | 300 | — | — |
| J1833 | Injection, isavuconazonium, 1 mg | 1 MG | $1.036 OPPS | 372 | — | — |
| J1836 | Injection, metronidazole, 10 mg | 10 MG | $0.034 | 400 | — | — |
| J1837 | Injection, posaconazole, 1 mg | 1 MG | $0.385 | 600 | — | — |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 15 MG | $0.569 | 8 | — | — |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 5 MG | $0.588 | — | — | — |
| J1921 | Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg | 5 MG | $0.874 | — | — | — |
| J1930 | Injection, lanreotide, 1 mg | 1 MG | $41.688 | 120 | — | — |
| J1931 | Injection, laronidase, 0.1 mg | 0.1 MG | $41.498 | 609 | — | — |
| J1932 | Injection, lanreotide, (cipla), 1 mg | 1 MG | $20.33 | 120 | — | — |
| J1938 | Injection, furosemide, 1 mg | 1 MG | $0.018 | 5360 | — | — |
| J1939 | Injection, bumetanide, 0.5 mg | 0.5 MG | $0.493 | 24 | — | — |
| J1943 | Injection, aripiprazole lauroxil, (aristada initio), 1 mg | 1 MG | $3.459 | 675 | — | — |
| J1944 | Injection, aripiprazole lauroxil, (aristada), 1 mg | 1 MG | $3.55 | 1064 | — | — |
| J1950 | Injection, leuprolide acetate (for depot suspension), per 3.75 mg | 3.75 MG | $1,799.052 | 12 | — | yes |
| J1951 | Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg | 0.25 MG | $141.696 | 180 | — | — |
| J1952 | Leuprolide injectable, camcevi, 1 mg | 1 mg | $36.373 | 42 | — | yes |
| J1954 | Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg | 7.5 MG | $683.86 | 3 | — | yes |
| J1955 | Injection, levocarnitine, per 1 gm | 1 GM | $24.375 | 11 | — | — |
| J1956 | Injection, levofloxacin, 250 mg | 250 MG | $2.565 | 4 | — | — |
| J1961 | Injection, lenacapavir (only for use as hiv treatment), 1 mg | 1 MG | $22.937 | — | — | — |
| J2002 | Injection, lidocaine hcl in 5% dextrose, 1 mg | 1 MG | $0.003 | 2000 | 7 | — |
| J2010 | Injection, lincomycin hcl, up to 300 mg | 300 MG | $3.69 | 10 | — | — |
| J2020 | Injection, linezolid, 200 mg | 200 MG | $2.431 | 6 | — | — |
| J2021 | Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg | 200 MG | $31.611 | 6 | — | — |
| J2060 | Injection, lorazepam, 2 mg | 2 MG | $2.197 | 4 | — | — |
| J2151 | Injection, mannitol, 250 mg | 250 MG | $0.112 | — | — | — |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 100 MG | $9.652 | 4 | — | — |
| J2182 | Injection, mepolizumab, 1 mg | 1 MG | $32.181 | 300 | — | — |
| J2183 | Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mg | 100 MG | $1.339 | 60 | — | — |
| J2184 | Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mg | 100 MG | $1.921 | 60 | — | — |
| J2185 | Injection, meropenem, 100 mg | 100 MG | $0.358 | 60 | — | — |
| J2186 | Injection, meropenem and vaborbactam, 10mg/10mg (20mg) | (10 MG/10MG) 20 MG | $2.267 OPPS | 600 | — | — |
| J2210 | Injection, methylergonovine maleate, up to 0.2 mg | 0.2 MG | $22.117 | 1 | — | — |
| J2246 | Injection, micafungin in sodium (baxter), not therapeutically equivalent to j2248, 1 mg | 1 MG | $0.334 | 150 | — | — |
| J2247 | Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mg | 1 MG | $0.219 | 150 | — | — |
| J2248 | Injection, micafungin sodium, 1 mg | 1 MG | $0.203 | 150 | — | — |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 1 MG | $0.167 | 22 | — | — |
| J2251 | Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg | 1 MG | $0.078 | 22 | — | — |
| J2260 | Injection, milrinone lactate, 5 mg | 5 MG | $1.143 | 4 | — | — |
| J2265 | Injection, minocycline hydrochloride, 1 mg | 1 MG | $2.79 OPPS | 400 | — | — |
| J2267 | Injection, mirikizumab-mrkz, 1 mg | 1 MG | $32.584 | 900 | — | — |
| J2270 | Injection, morphine sulfate, up to 10 mg | 10 MG | $7.259 | 9 | — | — |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 10 MG | $9.406 | 9 | — | — |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 10 MG | $16.044 | 250 | — | yes |
| J2277 | Injection, motixafortide, 0.25 mg | 0.25 MG | $26.479 | 750 | — | — |
| J2278 | Injection, ziconotide, 1 microgram | 1 MCG | $10.656 | 1000 | — | yes |
| J2280 | Injection, moxifloxacin, 100 mg | 100 MG | $8.744 | 4 | — | — |
| J2281 | Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to j2280, 100 mg | 100 MG | $6.641 | 4 | — | — |
| J2290 | Injection, nafcillin sodium, 20 mg | 20 MG | $0.047 | 300 | — | — |
| J2291 | Injection, nafcillin sodium (baxter), 20 mg | 20 MG | $0.135 | — | — | — |
| J2300 | Injection, nalbuphine hydrochloride, per 10 mg | 10 MG | $4.071 | 4 | — | — |
| J2305 | Injection, nitroglycerin, 5 mg | 5 MG | $1.542 | — | — | — |
| J2312 | Injection, naloxone hydrochloride, not otherwise specified, 0.01 mg | 0.01 MG | $0.076 | 1000 | — | — |
| J2315 | Injection, naltrexone, depot form, 1 mg | 1 MG | $4.537 | 380 | — | — |
| J2323 | Injection, natalizumab, 1 mg | 1 MG | $23.927 | 300 | — | — |
| J2326 | Injection, nusinersen, 0.1 mg | 0.1 MG | $706.049 OPPS | 500 | — | — |
| J2327 | Injection, risankizumab-rzaa, intravenous, 1 mg | 1 MG | $14.011 | 1200 | — | — |
| J2329 | Injection, ublituximab-xiiy, 1mg | 1 MG | $71.089 | — | — | — |
| J2350 | Injection, ocrelizumab, 1 mg | 1 MG | $60.689 | 600 | — | — |
| J2351 | Injection, ocrelizumab, 1 mg and hyaluronidase-ocsq | 1 MG | $47.287 | 920 | — | — |
| J2353 | Injection, octreotide, depot form for intramuscular injection, 1 mg | 1 MG | $211.321 | 60 | — | yes |
| J2354 | Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg | 25 MCG | $0.574 | 60 | — | — |
| J2356 | Injection, tezepelumab-ekko, 1 mg | 1 MG | $17.839 | 210 | — | — |
| J2357 | Injection, omalizumab, 5 mg | 5 MG | $45.687 | 120 | — | yes |
| J2358 | Injection, olanzapine, long-acting, 1 mg | 1 MG | $3.202 | 405 | — | — |
| J2359 | Injection, olanzapine, 0.5 mg | 0.5 MG | $0.615 | 60 | — | — |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 60 MG | $6.274 | 2 | — | — |
| J2361 | Injection, depemokimab-ulaa, 1 mg | 1 MG | $275.391 | — | — | — |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 20 MCG | $0.002 | — | — | — |
| J2372 | Injection, phenylephrine hydrochloride (biorphen), 20 micrograms | 20 MCG | $0.162 | — | — | — |
| J2373 | Injection, phenylephrine hydrochloride (immphentiv), 20 micrograms | 20 MCG | $0.136 | — | — | — |
| J2401 | Injection, chloroprocaine hydrochloride, per 1 mg | 1 MG | $0.045 | 1000 | — | — |
| J2403 | Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | 1 MG | $0.721 | 1600 | — | — |
| J2404 | Injection, nicardipine, 0.1 mg | 0.1 MG | $0.057 | 3600 | — | — |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1 MG | $0.084 | 64 | — | — |
| J2406 | Injection, oritavancin (kimyrsa), 10 mg | 10 MG | $44.392 | 120 | — | — |
| J2407 | Injection, oritavancin (orbactiv), 10 mg | 10 MG | $29.811 | 120 | — | — |
| J2425 | Injection, palifermin, 50 micrograms | 50 MCG | $38.839 | 125 | — | — |
| J2426 | Injection, paliperidone palmitate extended release (invega sustenna), 1 mg | 1 MG | $15.437 | 1560 | — | — |
| J2427 | Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg | 1MG | $13.246 | 1560 | — | — |
| J2428 | Injection, paliperidone palmitate extended release (erzofri), 1 mg | 1 MG | $15.587 | 351 | — | — |
| J2430 | Injection, pamidronate disodium, per 30 mg | 30 MG | $11.306 | 3 | — | yes |
| J2468 | Injection, palonosetron hydrochloride (posfrea), 25 micrograms | 25 MCG | $54.086 | 10 | — | — |
| J2469 | Injection, palonosetron hcl, 25 mcg | 25 MCG | $0.469 | 60 | — | — |
| J2501 | Injection, paricalcitol, 1 mcg | 1 MCG | $0.891 | 2 | — | — |
| J2502 | Injection, pasireotide long acting, 1 mg | 1 MG | $613.14 | 60 | — | — |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 0.5 MG | $201.241 | 12 | — | yes |
| J2507 | Injection, pegloticase, 1 mg | 1 MG | $4,000.629 | 8 | — | — |
| J2508 | Injection, pegunigalsidase alfa-iwxj, 1 mg | 1 MG | $225.998 | 160 | — | — |
| J2515 | Injection, pentobarbital sodium, per 50 mg | 50 MG | $20.309 OPPS | 1 | — | — |
| J2516 | Injection, pentamidine isethionate, 1 mg | 1 MG | $0.482 | 600 | — | — |
| J2540 | Injection, penicillin g potassium, up to 600,000 units | 600000 UNITS | $0.781 | 75 | — | — |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 1.125 GM | $1.183 | 16 | — | — |
| J2545 | Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg | 300 MG | $67.047 | 1 | — | — |
| J2547 | Injection, peramivir, 1 mg | 1 MG | $1.678 OPPS | 600 | — | — |
| J2550 | Injection, promethazine hcl, up to 50 mg | 50 MG | $3.241 | 3 | — | — |
| J2560 | Injection, phenobarbital sodium, up to 120 mg | 120 MG | $23.369 | 1 | — | — |
| J2562 | Injection, plerixafor, 1 mg | 1 MG | $42.943 | 48 | — | — |
| J2596 | Injection, vasopressin (long grove), not therapeutically equivalent to j2598, 1 unit | 1 UNIT | $1.712 | 160 | — | — |
| J2597 | Injection, desmopressin acetate, per 1 mcg | 1 MCG | $3.475 | 45 | — | — |
| J2598 | Injection, vasopressin, 1 unit | 1 UNIT | $0.566 | 160 | — | — |
| J2599 | Injection, vasopressin (american regent), not therapeutically equivalent to j2598, 1 unit | 1 UNIT | $0.574 | 160 | — | — |
| J2601 | Injection, vasopressin (baxter), 1 unit | 1 UNIT | $2.328 | 160 | — | — |
| J2675 | Injection, progesterone, per 50 mg | 50 MG | $0.623 | 1 | — | — |
| J2679 | Injection, fluphenazine hcl, 1.25 mg | 1.25 MG | $7.269 | 8 | — | — |
| J2680 | Injection, fluphenazine decanoate, up to 25 mg | 25 MG | $6.174 | 4 | — | — |
| J2690 | Injection, procainamide hcl, up to 1 gm | 1 GM | $394.868 | 4 | — | — |
| J2700 | Injection, oxacillin sodium, up to 250 mg | 250 MG | $0.768 | 48 | — | — |
| J2704 | Injection, propofol, 10 mg | 10 MG | $0.093 | 80 | — | — |
| J2720 | Injection, protamine sulfate, per 10 mg | 10 MG | $1.785 | 5 | — | — |
| J2724 | Injection, protein c concentrate, intravenous, human, 10 iu | 10 UNITS | $15.034 | 3500 | — | — |
| J2760 | Injection, phentolamine mesylate, up to 5 mg | 5 MG | $296.849 | 2 | — | — |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 10 MG | $0.891 | 10 | — | — |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 0.1 MG | $31.322 | 120 | — | yes |
| J2778 | Injection, ranibizumab, 0.1 mg | 0.1 mg | $26.384 | 10 | — | yes |
| J2779 | Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg | 0.1 MG | $73.542 | 200 | — | yes |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 1 MG | $135.267 | 30 | — | — |
| J2782 | Injection, avacincaptad pegol, 0.1 mg | 0.1 MG | $100.563 | 40 | — | — |
| J2783 | Injection, rasburicase, 0.5 mg | 0.5 MG | $386.628 | 60 | — | — |
| J2785 | Injection, regadenoson, 0.1 mg | 0.1 MG | $2.507 | 4 | — | yes |
| J2786 | Injection, reslizumab, 1 mg | 1 MG | $11.907 | 500 | — | — |
| J2788 | Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.) | 50 MCG (250 IU) | $27.653 | 1 | — | yes |
| J2789 | Riboflavin 5'-phosphate, ophthalmic solution (epioxahd/epioxa), up to 2 ml | UP TO 2 ML | $41,359.618 | — | — | — |
| J2790 | Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) | 300 MCG (1500 IU) | $82.081 | 1 | — | yes |
| J2791 | Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu | 100 IU | $4.837 | 15 | — | yes |
| J2792 | Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iu | 100 IU | $35.395 | 450 | 1 | yes |
| J2794 | Injection, risperidone (risperdal consta), 0.5 mg | 0.5 MG | $10.662 | 100 | — | — |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 1 MG | $0.04 | 200 | — | — |
| J2798 | Injection, risperidone, (perseris), 0.5 mg | 0.5 mg | $12.191 | 240 | — | — |
| J2799 | Injection, risperidone (uzedy), 1 mg | 1 MG | $26.227 | 250 | — | — |
| J2800 | Injection, methocarbamol, up to 10 ml | 10 ML | $3.839 | 3 | — | — |
| J2801 | Injection, risperidone (rykindo), 0.5 mg | 0.5 mg | $13.03 OPPS | 100 | — | — |
| J2802 | Injection, romiplostim, 1 microgram | 1 MCG | $11.713 | 1500 | — | — |
| J2804 | Injection, rifampin, 1 mg | 1 MG | $0.165 | 1200 | — | — |
| J2805 | Injection, sincalide, 5 micrograms | 5 MCG | $145.638 | 3 | — | — |
| J2820 | Injection, sargramostim (gm-csf), 50 mcg | 50 MCG | $62.47 | 15 | — | yes |
| J2840 | Injection, sebelipase alfa, 1 mg | 1 MG | $539.585 OPPS | 160 | — | — |
| J2850 | Injection, secretin, synthetic, human, 1 microgram | 1 MCG | $43.741 OPPS | 16 | — | — |
| J2860 | Injection, siltuximab, 10 mg | 10 MG | $178.427 | 170 | — | — |
Show the other 7 codes on this page (pages not yet in search results)
- J1807 Injection, ethacrynate sodium, 1 mg · OPPS $9.941
- J1818 Injection, pegzilarginase-nbln, 0.05 mg · OPPS $298.77
- J1834 Injection, isoniazid, 1 mg · OPPS $0.303
- J1957 Injection, levetiracetam, 5 mg · limit $0.013
- J1958 Injection, levetiracetam in sodium chloride, 5 mg · limit $0.033
- J2374 Apraclonidine hydrochloride ophthalmic, 1% solution, 0.1 ml · limit $28.804
- J2561 Injection, phenobarbital sodium (sezaby), 1 mg · OPPS $0.038
How to read this page
The limit is the Medicare Part B payment allowance per billing unit for the October 2026 quarter, not per dose: divide the quantity administered by the unit in the descriptor to get the units billed, then multiply. Codes marked OPPS have no ASP limit and show the hospital outpatient rate per unit instead, and codes without a limit are priced by the contractor or carry a limit of zero in the CMS file. The MUE column is the practitioner Medically Unlikely Edit, the most units CMS expects on one date of service; the facility and supplier limits can differ and are on each code page. Column-2 pairs counts the active NCCI procedure-to-procedure edits in which the code is the bundled component, and Articles marks codes that a Medicare Administrative Contractor lists in a current billing and coding article.
Codes are listed in code order across 6 pages, and every code of the hub appears on exactly one of them. A code shown as text still has its own reference page with the same data; that page is kept out of search results because fewer CMS files join to the code, few people search for it, or its text is too close to another code's page, and the hub links the pages that are meant to be found. Amounts are Medicare national figures before locality and state adjustment.
Finding a code faster
Look up any code by number with the code search, or go back to the Drugs administered other than oral method, chemotherapy drugs (J codes) hub for its most searched codes and the answers to common questions. The MUE lookup shows every unit limit for a code, the NCCI edit checker tests whether two codes are bundled, and the HCPCS code lookup lists every range, drug and drug-class hub. For a drug you know by name, the J code index by drug name lists every code a generic or brand name bills under, and the ASP pricing file guide explains how the quarterly limits are set.
For teams evaluating QuickIntell software
Evaluate software for HCPCS coding workflows
Evaluating a recurring coding workflow? Review QuickCode for qualified coder review, documentation clarification and the billing handoff. Use your unit, modifier and edit questions to confirm the supported scope; a published CMS table does not establish an automated claim check.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- Medicare Part B Drug Payment Limit File, October 2026Version October 2026 · effective 2026-10-01 · file section 508 version of October 2026 Medicare Part B Payment Limit File 091626.csvSHA-256 508fba376a29e099…
- NCCI MUE table, practitioner services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_PractitionerServices_Eff_10-01-2026.csvSHA-256 ef038efaf902b7bd…
- NCCI PTP edits, practitioner, v323r0 (four files)Version v323r0 (2026 Q4) · effective 2026-10-01 · file ccipra-v323r0-f1.TXTSHA-256 7793c0b6686c1e22…
- OPPS Addendum B, October 2026Version October 2026 · effective 2026-10-01 · file 508-compliant-version-2026_October_Web_Addendum_B.09.28.26.csvSHA-256 6ad7393a318bf1b9…
Disclaimer
Operational reference compiled from CMS publications. Amounts are Medicare national figures before locality and state adjustment; other payers differ. CPT codes appear as numbers only. This continuation page is kept out of search results; the hub and each code's own page are the pages meant to be found. Not legal, clinical or billing advice.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.